Evaluation of β-cyclodextrin-modified gemini surfactant-based delivery systems in melanoma models

Novel drug delivery systems are developed to improve the biological behavior of poorly soluble drugs and to improve therapeutic outcomes. In melanoma therapy, the goal is efficient drug delivery and mitigation of drug resistance. Melphalan (Mel), a currently used therapeutic agent for melanoma, requ...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Int J Nanomedicine
Главные авторы: Michel, Deborah, Mohammed-Saeid, Waleed, Getson, Heather, Roy, Caitlin, Poorghorban, Masoomeh, Chitanda, Jackson M, Verrall, Ronald, Badea, Ildiko
Формат: Artigo
Язык:Inglês
Опубликовано: Dove Medical Press 2016
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5161338/
https://ncbi.nlm.nih.gov/pubmed/28003746
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S121156
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы